Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Income Statement [Abstract]      
Revenue
Operating expenses:      
Research and development, net of reimbursements 17,699,503 17,786,655 13,501,895
General and administrative 9,155,347 8,983,303 11,274,404
Depreciation expense 55,938 77,523 53,465
Total operating expenses 26,910,788 26,847,481 24,829,764
Loss from operations (26,910,788) (26,847,481) (24,829,764)
Other income (expense):      
Interest income (expense) 5,430 (5,007) (7,868)
Gain on change in fair value of derivative liabilities 304,123 2,530,764 3,812,318
Total other income (expense) 309,553 2,525,757 3,804,450
Net loss $ (26,601,235) $ (24,321,724) $ (21,025,314)
Net loss per common share - basic and diluted $ (0.4) $ (0.5) $ (0.55)
Weighted average common shares outstanding - basic and diluted 66,746,389 48,463,268 38,158,480